Skip to main content
. 2006 Mar 7;108(1):28–37. doi: 10.1182/blood-2006-01-0092

Table 2.

Technologies available for identifying and quantifying BCR-ABL KD mutations

Technology Sensitivity, % Specificity Bias* Availability Reference
Direct sequencing 15-25 ++ No +++ 19,21,22,24,59
Subcloning and sequencing 9 +++ No ++ 20
Denaturing high-performance liquid chromatography (D-HPLC) 0.1-10 ++ No ++ 66-68
Pyrosequencing 5 ++ No + 55,69
Double-gradient denaturing electrophoresis 5 ++ No + 57
Fluorescence PCR and PNA clamping 0.2 ++ Yes + 58
Allele-specific oligonucleotide PCR (ASO-PCR) 0.01 ++ Yes + 53,59,60

PNA indicates peptide nucleic acid.

*

Bias indicates that the test is designed to detect specific mutations.